#London #United Kingdom #Powtoon #Visual Pharma #LTEN Excellence

Visual Pharma by Powtoon: A Trailblazer in AI-Powered Scientific Communication

In a significant recognition of innovation within the pharmaceutical industry, Visual Pharma by Powtoon has earned a finalist position at the 2026 LTEN Excellence Awards. This accolade, specifically in the Innovative Design & Solutions category, highlights the company's pioneering efforts in facilitating scientific communication through its state-of-the-art tool, MOA Studio.

MOA Studio represents a transformative solution designed to address a significant challenge faced by many in the medical field: the translation of complex clinical data into highly accurate visual content. Traditionally, the production of Mechanism-of-Action (MOA) videos has been an arduous process, heavily relying on external agencies, which can lead to prolonged timelines and exorbitant costs—ranging from weeks to tens of thousands of dollars for each asset. These challenges can substantially hamper the speed and effectiveness of communication across the product lifecycle, from initial clinical discussions to product launch and subsequent updates.

What is MOA Studio?

MOA Studio is not just another video creation tool; it is a revolutionary platform built on a robust AI framework that is meticulously aligned with clinical source documentation. It empowers Medical Affairs and learning teams to create scientifically accurate visual content swiftly—within a matter of hours. The platform emphasizes reliability and compliance through:

• - Human-in-the-Loop Validation: Ensures that content is vetted by professionals, aligning with medical standards.
• - Compliance Checkpoints: Keeps all communications officially in line with regulatory requirements.
• - Brand Controls: Guarantees that the messaging aligns with brand integrity.
• - Version-Controlled Audit Trails: Maintains comprehensive records for accountability and traceability.

Ilya Spitalnik, the CEO of Powtoon, expressed gratitude for this recognition, stating, "We're honored to be recognized by LTEN. This reflects a broader shift across pharma. The challenge is no longer just creating content, it's enabling knowledge to move faster across teams, while maintaining the highest standards of scientific accuracy and compliance. MOA Studio was built to support exactly that."

The Long-term Impact of Efficient Communication

The adoption of MOA Studio not only offers immediate benefits but also positions organizations for long-term success. It substantially lowers production costs and accelerates the time to market while reducing reliance on external vendors. Furthermore, it allows for continuous updates of scientific content as new evidence becomes available, ensuring that teams remain informed and current.

MOA Studio also enhances educational outcomes by transforming dense clinical data into engaging, narrative-driven visuals. This transformation leads to improved engagement, retention, and knowledge assimilation among field teams and healthcare professionals.

Looking Ahead

Winners of the LTEN Excellence Awards will be announced during the organization’s Annual Conference in June. Powtoon is set to amplify the capabilities of MOA Studio at its upcoming Triple AI Unboxing event on May 20. Attendees will also get a glimpse of additional workflows designed to bridge knowledge transfer gaps within enterprise teams, further showcasing Powtoon’s dedication to advancing communication in the pharmaceutical sector.

In conclusion, Visual Pharma by Powtoon’s recognition at the LTEN Excellence Awards not only highlights the importance of innovative solutions in pharmaceutical communication but also sets a benchmark for future advancements in the industry. As companies continue to face challenges in clinical data dissemination, tools like MOA Studio are proving essential in fostering efficient, compliant, and effective communication throughout the product lifecycle.